Strategic Partnerships Kela has recently announced a dual branded pet gastrointestinal health range and a partnership with Mervue laboratories to launch it across Belgium, Luxembourg, and the Netherlands. This indicates a clear opportunity to propose complementary CDMO services, regulatory support, or contract manufacturing enhancements to scale the new product line or similar collaborations.

Veterinary CDMO Focus As an established veterinary CDMO with expertise in penicillin and non-beta-lactam injectables and a track record in complex manufacturing, Kela is likely seeking scalable manufacturing, quality systems optimization, and global registrations support to expand animal health products in international markets.

Growth through Acquisitions Kela’s growth model emphasizes acquisitions and targeted hiring to build R&D, production, and regulatory capabilities. This suggests potential fit for inorganic growth services, integration programs, and risk-managed transition support for potential acquisitions or portfolio expansions.

Digital & Analytics Readiness Utilizing a tech stack that includes Salesforce, Google Analytics, and other analytics tools indicates a data-driven sales and marketing approach. There is an opportunity to offer CRM optimization, analytics-driven demand generation, and e-commerce or partner portal enhancements to accelerate go-to-market activities.

Regional Expansion Active presence in Belgium, Luxembourg, and the Netherlands with a Belgian origin suggests appetite for regional expansion. Sales can target regional distributors, veterinary clinics, and animal health networks, offering regulatory affairs, supply chain scalability, and local market entry support to accelerate market penetration.